This report studies MAb Biosimilars in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Biocon Celltrion Dr. Reddy's Laboratories Hospira 3SBio Accord Healthcare AET Biotech Allergan Alvartis Pharma Amega Biotech Amgen Apotex BioXpress Therapeutics Natco Pharma Sanifo Synthon By types, the market can be split into Synthetic chemicls Biopharmaceuticals Others By Application, the market can be split into Chronic and autoimmune diseases Oncology By Regions, this report covers (we can add the regions/countries as you want) North America China Europe Southeast Asia Japan India
Table of Contents Global MAb Biosimilars Market Professional Survey Report 2017 1 Industry Overview of MAb Biosimilars 1.1 Definition and Specifications of MAb Biosimilars 1.1.1 Definition of MAb Biosimilars 1.1.2 Specifications of MAb Biosimilars 1.2 Classification of MAb Biosimilars 1.2.1 Synthetic chemicls 1.2.2 Biopharmaceuticals 1.2.3